1 |
Edetic acid
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
2 |
Estrone
| - | 0件: | - | - | - |
3 |
Epinephrine
| 1件: Epinephrine Epinephrine | 3件: Epinephrine Epinephrine; Lidocaine; Xylocaine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 46 46, 70, 96 |
4 |
Estradiol
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
5 |
Epoprostenol
| 1件: Epoprostenol Epoprostenol | 6件: EPOPROSTENOL EPOPROSTENOL; Epoprostenol for injection; EPOPROSTENOL SODIUM; Flolan; Prostacyclin; Veletri; | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
6 |
Ephedrine
| 1件: Ephedrine Ephedrine | 2件: Efedrina Efedrina; Ephedrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 |
7 |
Etoposide
| 1件: Etoposide Etoposide | 1件: Etoposide Etoposide; | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
8 |
Erythromycin
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
9 |
Eptacog alfa
| 1件: Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | 1件: RFVIIa RFVIIa; | - | - | 1件: 288 288 |
10 |
Estriol
| 1件: Estriol Estriol | 1件: Estriol Estriol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 13 13, 227 |
11 |
Ergocalciferol
| 1件: Ergocalciferol Ergocalciferol | 3件: Ergocalciferol Ergocalciferol; Vitamin D; Vitamin D2; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 6件: 46 46, 49, 84, 96, 97, 299 |
12 |
Enoxacin
| 1件: Enoxacin Enoxacin | 1件: Enoxacin Enoxacin; | - | - | 1件: 2 2 |
13 |
Estazolam
| - | 0件: | - | - | - |
14 |
Estrone sodium sulfate
| - | 0件: | - | - | - |
15 |
Ethacrynic acid
| - | 0件: | - | - | - |
16 |
Etidronate disodium
| - | 0件: | - | - | - |
17 |
Etodolac
| 1件: Etodolac Etodolac | 1件: Etodolac Etodolac; | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
18 |
Etretinate
| - | 0件: | - | - | - |
19 |
Ethosuximide
| - | 0件: | - | - | - |
20 |
Enflurane
| - | 0件: | - | - | - |
21 |
Etomidate
| 1件: Etomidate Etomidate | 1件: Etomidate Etomidate; | 1件: GABRA1 GABRA1 💬 | 6件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬 | 1件: 6 6 |
22 |
Ethinyl estradiol
| 1件: Ethinylestradiol Ethinylestradiol | 3件: Ethinyl estradiol Ethinyl estradiol; ETHINYLESTRADIOL; Ortho-Novum 777; | 1件: ESR1 ESR1 💬 | 9件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 13 13, 46, 49, 299 |
23 |
Edetate calcium disodium anhydrous
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
24 |
Ethionamide
| - | 0件: | - | - | - |
25 |
Enalapril maleate
| 1件: Enalapril Enalapril | 2件: Enalapril Enalapril; Enalapril Maleate; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 6件: 19 19, 46, 66, 113, 210, 222 |
26 |
Esmolol hydrochloride
| 1件: Esmolol Esmolol | 1件: Esmolol Esmolol; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
27 |
Ergotamine tartrate
| - | 0件: | - | - | - |
28 |
Ethinamate
| - | 0件: | - | - | - |
29 |
Ethchlorvynol
| - | 0件: | - | - | - |
30 |
Ethotoin
| - | 0件: | - | - | - |
31 |
Etanercept
| 1件: Etanercept Etanercept | 4件: Benepali Benepali; Enbrel; Erelzi; Etanercept; | 2件: LTA LTA, TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 17件: 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298 |
32 |
Entacapone
| 1件: Entacapone Entacapone | 5件: COMTAN COMTAN; Comtess; ENTACAPONA; ENTACAPONE; Stalevo; | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
33 |
Erythromycin estolate
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
34 |
Ethambutol hydrochloride
| 1件: Ethambutol Ethambutol | 1件: Ethambutol Ethambutol; | - | - | 2件: 84 84, 299 |
35 |
Econazole nitrate
| - | 0件: | - | - | - |
36 |
Efavirenz
| 1件: Efavirenz Efavirenz | 2件: Efavirenz Efavirenz; SUSTIVA; | - | - | 1件: 265 265 |
37 |
Exemestane
| - | 0件: | - | - | - |
38 |
Edrophonium chloride
| - | 0件: | - | - | - |
39 |
Epinephrine hydrochloride
| 1件: Epinephrine Epinephrine | 3件: Epinephrine Epinephrine; Lidocaine; Xylocaine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 46 46, 70, 96 |
40 |
Emivirine
| - | 0件: | - | - | - |
41 |
Exametazime
| 1件: Exametazime Exametazime | 1件: Exametazime Exametazime; | - | - | 1件: 6 6 |
42 |
Ethylenediamine
| - | 0件: | - | - | - |
43 |
Eplerenone
| 1件: Eplerenone Eplerenone | 1件: Eplerenone Eplerenone; | 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 4件: 75 75, 113, 210, 215 |
44 |
Efloxate
| - | 0件: | - | - | - |
45 |
Ergonovine maleate
| - | 0件: | - | - | - |
46 |
Ethylphenacemide
| - | 0件: | - | - | - |
47 |
Emtricitabine
| 1件: Emtricitabine Emtricitabine | 2件: Emtricitabine Emtricitabine; TRUVADA; | - | - | 4件: 25 25, 93, 265, 325 |
48 |
Ethamsylate
| 1件: Etamsylate Etamsylate | 1件: ETAMSYLATE ETAMSYLATE; | - | - | 1件: 227 227 |
49 |
Ethyl loflazepate
| - | 0件: | - | - | - |
50 |
Ethynodiol diacetate
| - | 0件: | - | - | - |
51 |
Epoprostenol sodium
| 1件: Epoprostenol Epoprostenol | 6件: EPOPROSTENOL EPOPROSTENOL; Epoprostenol for injection; EPOPROSTENOL SODIUM; Flolan; Prostacyclin; Veletri; | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
52 |
Erythromycin ethylsuccinate
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
53 |
Epirizole
| - | 0件: | - | - | - |
54 |
Estradiol valerate
| 2件: Estradiol Estradiol, Estradiol valerate | 2件: Estradiol Estradiol; Estradiol valerate; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 8件: 13 13, 46, 49, 65, 65, 76, 226, 299 |
55 |
Ethylestrenol
| - | 0件: | - | - | - |
56 |
Ethenzamide
| - | 0件: | - | - | - |
57 |
Esatenolol
| - | 0件: | - | - | - |
58 |
Ebastine
| - | 0件: | - | - | - |
59 |
Etizolam
| 1件: Etizolam Etizolam | 0件: | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 46 46 |
60 |
Ethyl piperidinoacetylaminobenzoate
| - | 0件: | - | - | - |
61 |
Edaravone
| 1件: Edaravone Edaravone | 3件: EDARAVONE EDARAVONE; Methylphenylpyrazolone; Norphenazone; | - | - | 2件: 2 2, 22 |
62 |
Estradiol dipropionate
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
63 |
Epalrestat
| - | 0件: | - | - | - |
64 |
Epinastine hydrochloride
| - | 0件: | - | - | - |
65 |
Ether
| 1件: Diethyl ether Diethyl ether | 1件: Ether Ether; | - | - | 1件: 235 235 |
66 |
Edetate disodium
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
67 |
Enprostil
| - | 0件: | - | - | - |
68 |
Estradiol benzoate
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
69 |
Ezetimibe
| 1件: Ezetimibe Ezetimibe | 2件: Ezetimibe Ezetimibe; Ezetrol; | 1件: NPC1L1 NPC1L1 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 4件: 49 49, 79, 93, 260 |
70 |
Eletriptan hydrobromide
| - | 0件: | - | - | - |
71 |
Esomeprazole magnesium
| 1件: Esomeprazole Esomeprazole | 3件: Esomeprazole Esomeprazole; Nexium; Omeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
72 |
Estriol tripropionate
| 1件: Estriol Estriol | 1件: Estriol Estriol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 13 13, 227 |
73 |
Erythromycin lactobionate
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
74 |
Eprosartan mesylate
| - | 0件: | - | - | - |
75 |
Epinephrine bitartrate
| 1件: Epinephrine Epinephrine | 3件: Epinephrine Epinephrine; Lidocaine; Xylocaine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 46 46, 70, 96 |
76 |
Erythromycin stearate
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
77 |
Echothiophate iodide
| - | 0件: | - | - | - |
78 |
Epirubicin hydrochloride
| - | 0件: | - | - | - |
79 |
Emedastine difumarate
| - | 0件: | - | - | - |
80 |
Ergoloid mesylates
| 1件: Ergoloid mesylate Ergoloid mesylate | 2件: Dihydroergotoxine Mesylate Dihydroergotoxine Mesylate; Ergoloid Mesylate; | 6件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 206 |
81 |
Ethanolamine oleate
| 1件: Ethanolamine oleate Ethanolamine oleate | 1件: Ethanolamine oleate Ethanolamine oleate; | - | - | 1件: 279 279 |
82 |
Etidronic acid
| - | 0件: | - | - | - |
83 |
Estramustine phosphate sodium
| - | 0件: | - | - | - |
84 |
Ethoxzolamide
| - | 0件: | - | - | - |
85 |
Enrofloxacin
| - | 0件: | - | - | - |
86 |
Enfuvirtide
| 1件: Enfuvirtide Enfuvirtide | 1件: Enfuvirtide Enfuvirtide; | - | - | 2件: 25 25, 265 |
87 |
Erythromycin acistrate
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
88 |
Erythromycin gluceptate
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
89 |
Erythromycin propionate
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
90 |
Escitalopram oxalate
| 1件: Escitalopram Escitalopram | 3件: Citalopram Citalopram; Escitalopram; Escitalopram oxalate; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 13 |
91 |
Eszopiclone
| 1件: Eszopiclone Eszopiclone | 2件: Eszopiclone Eszopiclone; Zopiclone; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 13, 46 |
92 |
Everolimus
| 1件: Everolimus Everolimus | 4件: Afinitor Afinitor; Certican; Everolimus; Votubia; | 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 9件: 34 34, 67, 89, 96, 137, 157, 158, 228, 277 |
93 |
Ecraprost
| - | 0件: | - | - | - |
94 |
Epoetin alfa
| 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa Epoetin alfa; Epoetin beta; Erythropoietin; NeoRecormon; | 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 10件: 2 2, 6, 13, 18, 22, 46, 47, 70, 95, 96 |
95 |
Elcatonin
| - | 0件: | - | - | - |
96 |
Enoxaparin sodium
| 1件: Enoxaparin Enoxaparin | 1件: Enoxaparin Enoxaparin; | 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 46 46 |
97 |
Etoricoxib
| 1件: Etoricoxib Etoricoxib | 1件: ETORICOXIB ETORICOXIB; | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 |
98 |
Enalkiren
| - | 0件: | - | - | - |
99 |
Enalaprilat
| - | 0件: | - | - | - |
100 |
Ecallantide
| - | 0件: | - | - | - |
101 |
Ecamsule
| - | 0件: | - | - | - |
102 |
Econazole
| - | 0件: | - | - | - |
103 |
Ecromeximab
| - | 0件: | - | - | - |
104 |
Eculizumab
| 1件: Eculizumab Eculizumab | 2件: ECULIZUMAB ECULIZUMAB; SOLIRIS; | 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 11 11, 13, 14, 61, 62, 109, 222 |
105 |
Edetate calcium disodium
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
106 |
Edetate dipotassium
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
107 |
Edetate sodium
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
108 |
Edetate trisodium
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
109 |
Edifoligide sodium
| - | 0件: | - | - | - |
110 |
Edodekin alfa
| - | 0件: | - | - | - |
111 |
Edotecarin
| - | 0件: | - | - | - |
112 |
Edoxudine
| - | 0件: | - | - | - |
113 |
Edratide
| 1件: Edratide Edratide | 1件: Edratide Edratide; | - | - | 1件: 49 49 |
114 |
Edrecolomab
| - | 0件: | - | - | - |
115 |
Efalizumab
| 1件: Efalizumab Efalizumab | 2件: EFALIZUMAB EFALIZUMAB; Raptiva; | 1件: ITGAL ITGAL 💬 | 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 9件: 11 11, 13, 37, 46, 49, 53, 61, 95, 96 |
116 |
Efaproxiral
| - | 0件: | - | - | - |
117 |
Efrotomycin
| - | 0件: | - | - | - |
118 |
Elm
| - | 0件: | - | - | - |
119 |
Elsamitrucin
| - | 0件: | - | - | - |
120 |
Elvucitabine
| - | 0件: | - | - | - |
121 |
Embutramide
| - | 0件: | - | - | - |
122 |
Encainide hydrochloride
| - | 0件: | - | - | - |
123 |
Eniluracil
| - | 0件: | - | - | - |
124 |
Enoximone
| - | 0件: | - | - | - |
125 |
Enprofylline
| - | 0件: | - | - | - |
126 |
Entecavir
| 1件: Entecavir Entecavir | 1件: Entecavir Entecavir; | - | - | 6件: 46 46, 56, 96, 97, 107, 271 |
127 |
Enzacamene
| - | 0件: | - | - | - |
128 |
Epafipase
| - | 0件: | - | - | - |
129 |
Epicillin
| - | 0件: | - | - | - |
130 |
Epimestrol
| - | 0件: | - | - | - |
131 |
Erlotinib hydrochloride
| 1件: Erlotinib Erlotinib | 1件: Erlotinib Erlotinib; | 1件: EGFR EGFR 💬 | 48件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | 1件: 94 94 |
132 |
Epoetin delta
| - | 0件: | - | - | - |
133 |
Epithiazide
| - | 0件: | - | - | - |
134 |
Epratuzumab
| 1件: Epratuzumab Epratuzumab | 1件: EPRATUZUMAB EPRATUZUMAB; | 1件: CD22 CD22 💬 | 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 |
135 |
Eprinomectin
| - | 0件: | - | - | - |
136 |
Eprosartan
| - | 0件: | - | - | - |
137 |
Equilin
| - | 0件: | - | - | - |
138 |
Ertapenem sodium
| - | 0件: | - | - | - |
139 |
Ertiprotafib
| - | 0件: | - | - | - |
140 |
Erythrityl tetranitrate
| 1件: Erythrityl tetranitrate Erythrityl tetranitrate | 0件: | 2件: NPR1 NPR1, NPR2 💬 | 10件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Oxytocin signaling pathway, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
141 |
Erythromycin salnacedin
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin; | - | - | 5件: 6 6, 36, 164, 228, 291 |
142 |
Esmirtazapine maleate
| - | 0件: | - | - | - |
143 |
Esomeprazole sodium
| 1件: Esomeprazole Esomeprazole | 3件: Esomeprazole Esomeprazole; Nexium; Omeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
144 |
Estradiol acetate
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
145 |
Estradiol cypionate
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
146 |
Estradiol enanthate
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
147 |
Estradiol undecylate
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
148 |
Estramustine
| - | 0件: | - | - | - |
149 |
Estrogens, conjugated
| 1件: Conjugated estrogens Conjugated estrogens | 1件: Conjugated equine estrogens Conjugated equine estrogens; | - | - | 1件: 49 49 |
150 |
Etalocib
| - | 0件: | - | - | - |
151 |
Etanidazole
| - | 0件: | - | - | - |
152 |
Ethiodized oil
| 1件: Ethiodized oil Ethiodized oil | 1件: Lipiodol Lipiodol; | - | - | 1件: 280 280 |
153 |
Ethiodized oil I 131
| 1件: Ethiodized oil Ethiodized oil | 1件: Lipiodol Lipiodol; | - | - | 1件: 280 280 |
154 |
Ethybenztropine
| - | 0件: | - | - | - |
155 |
Ethyl chloride
| - | 0件: | - | - | - |
156 |
Etryptamine acetate
| - | 0件: | - | - | - |
157 |
Etidocaine
| - | 0件: | - | - | - |
158 |
Etilevodopa
| - | 0件: | - | - | - |
159 |
Etiprednol dicloacetate
| 1件: Etiprednol dicloacetate Etiprednol dicloacetate | 1件: Etiprednol dicloacetate Etiprednol dicloacetate; | - | - | 1件: 96 96 |
160 |
Etofenamate
| - | 0件: | - | - | - |
161 |
Etonogestrel
| - | 0件: | - | - | - |
162 |
Etoposide phosphate
| 1件: Etoposide Etoposide | 1件: Etoposide Etoposide; | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
163 |
Etravirine
| 1件: Etravirine Etravirine | 3件: ETRAVIRINA ETRAVIRINA; Etravirine; INTELENCE; | - | - | 1件: 18 18 |
164 |
Eucalyptol
| - | 0件: | - | - | - |
165 |
Eugenol
| - | 0件: | - | - | - |
166 |
Evernimicin
| - | 0件: | - | - | - |
167 |
Exenatide
| 1件: Exenatide Exenatide | 3件: Bydureon Bydureon; Byetta; Exenatide; | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 6 6, 17, 72, 78, 193, 233 |
168 |
Esculoside
| - | 0件: | - | - | - |
169 |
Ethanol for disinfection
| 1件: Ethanol Ethanol | 3件: Alcohol Alcohol; Ethanol; Prednisone; | - | - | 7件: 13 13, 51, 58, 97, 279, 280, 298 |
170 |
Eucalyptus oil
| - | 0件: | - | - | - |
171 |
Enoxacin hydrate
| 1件: Enoxacin Enoxacin | 1件: Enoxacin Enoxacin; | - | - | 1件: 2 2 |
172 |
Estramustine phosphate sodium hydrate
| - | 0件: | - | - | - |
173 |
Ethanol
| 1件: Ethanol Ethanol | 3件: Alcohol Alcohol; Ethanol; Prednisone; | - | - | 7件: 13 13, 51, 58, 97, 279, 280, 298 |
174 |
Epanolol
| - | 0件: | - | - | - |
175 |
Elvitegravir
| - | 0件: | - | - | - |
176 |
Eptifibatide
| - | 0件: | - | - | - |
177 |
Etilamfetamine
| - | 0件: | - | - | - |
178 |
Ethyl biscoumacetate
| - | 0件: | - | - | - |
179 |
Etofibrate
| - | 0件: | - | - | - |
180 |
Etoglucid
| - | 0件: | - | - | - |
181 |
Esketamine
| 1件: Esketamine Esketamine | 3件: Esketamine Esketamine; KETAMINE; S-ketamine; | 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 4, 70 |
182 |
Emylcamate
| - | 0件: | - | - | - |
183 |
Etifoxine
| 1件: Etifoxine Etifoxine | 1件: Etifoxine Etifoxine; | - | - | 1件: 13 13 |
184 |
Etofamide
| - | 0件: | - | - | - |
185 |
Etamiphylline
| - | 0件: | - | - | - |
186 |
Eprozinol
| - | 0件: | - | - | - |
187 |
Erdosteine
| - | 0件: | - | - | - |
188 |
Eptotermin alfa
| - | 0件: | - | - | - |
189 |
Eldecalcitol
| 1件: Eldecalcitol Eldecalcitol | 1件: Eldecalcitol Eldecalcitol; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 46 46 |
190 |
Eberconazole
| - | 0件: | - | - | - |
191 |
Eflornithine
| 1件: Eflornithine Eflornithine | 1件: Eflornithine Eflornithine; | 1件: ODC1 ODC1 💬 | 3件: Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬 | 1件: 65 65 |
192 |
Ecabet
| - | 0件: | - | - | - |
193 |
Efonidipine
| - | 0件: | - | - | - |
194 |
Eletriptan
| - | 0件: | - | - | - |
195 |
Emedastine
| - | 0件: | - | - | - |
196 |
Enalapril
| 1件: Enalapril Enalapril | 2件: ENALAPRIL ENALAPRIL; Enalapril Maleate; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 6件: 19 19, 46, 66, 113, 210, 222 |
197 |
Enbucrilate
| - | 0件: | - | - | - |
198 |
Encainide
| - | 0件: | - | - | - |
199 |
Entecavir
| 1件: Entecavir Entecavir | 1件: Entecavir Entecavir; | - | - | 6件: 46 46, 56, 96, 97, 107, 271 |
200 |
Enviomycin
| - | 0件: | - | - | - |
201 |
Eperisone
| 1件: Eperisone Eperisone | 1件: EPERISONE EPERISONE; | - | - | 1件: 2 2 |
202 |
Epinastine
| - | 0件: | - | - | - |
203 |
Epirubicin
| - | 0件: | - | - | - |
204 |
Eprazinone
| - | 0件: | - | - | - |
205 |
Ergometrine
| - | 0件: | - | - | - |
206 |
Ergotamine
| - | 0件: | - | - | - |
207 |
Erlotinib
| 1件: Erlotinib Erlotinib | 1件: Erlotinib Erlotinib; | 1件: EGFR EGFR 💬 | 48件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | 1件: 94 94 |
208 |
Ertapenem
| - | 0件: | - | - | - |
209 |
Escitalopram
| 1件: Escitalopram Escitalopram | 3件: Citalopram Citalopram; Escitalopram; Escitalopram oxalate; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 13 |
210 |
Esmolol
| 1件: Esmolol Esmolol | 1件: Esmolol Esmolol; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
211 |
Esomeprazole
| 1件: Esomeprazole Esomeprazole | 3件: Esomeprazole Esomeprazole; Nexium; Omeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
212 |
Etafenone
| - | 0件: | - | - | - |
213 |
Ethacridine
| - | 0件: | - | - | - |
214 |
Ethambutol
| 1件: Ethambutol Ethambutol | 1件: Ethambutol Ethambutol; | - | - | 2件: 84 84, 299 |
215 |
Ethylmorphine
| - | 0件: | - | - | - |
216 |
Etilefrine
| - | 0件: | - | - | - |
217 |
Etorphine
| - | 0件: | - | - | - |
218 |
Etynodiol
| - | 0件: | - | - | - |
219 |
Endralazine
| - | 0件: | - | - | - |
220 |
Elesclomol
| - | 0件: | - | - | - |
221 |
Enclomiphene
| - | 0件: | - | - | - |
222 |
Eribaxaban
| - | 0件: | - | - | - |
223 |
Erythritol
| - | 0件: | - | - | - |
224 |
Eslicarbazepine
| - | 0件: | - | - | - |
225 |
Elagolix
| - | 0件: | - | - | - |
226 |
Elotuzumab
| 1件: Elotuzumab Elotuzumab | 1件: Elotuzumab Elotuzumab; | 1件: SLAMF7 SLAMF7 💬 | - | 2件: 28 28, 300 |
227 |
Entinostat
| - | 0件: | - | - | - |
228 |
Esomeprazole potassium
| 1件: Esomeprazole Esomeprazole | 3件: Esomeprazole Esomeprazole; Nexium; Omeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
229 |
Esreboxetine
| - | 0件: | - | - | - |
230 |
Etaracizumab
| - | 0件: | - | - | - |
231 |
Ezogabine
| 1件: Ezogabine Ezogabine | 4件: Ezogabine Ezogabine; Potiga; RETIGABINE; Trobalt; | 5件: KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | 6件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | 2件: 2 2, 144 |
232 |
Elinogrel
| - | 0件: | - | - | - |
233 |
Emicerfont
| - | 0件: | - | - | - |
234 |
Eslicarbazepine acetate
| - | 0件: | - | - | - |
235 |
Evatanepag
| - | 0件: | - | - | - |
236 |
Edoxaban
| 1件: Edoxaban Edoxaban | 1件: Edoxaban Edoxaban; | 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 46 46, 88 |
237 |
Efungumab
| - | 0件: | - | - | - |
238 |
Elacytarabine
| - | 0件: | - | - | - |
239 |
Edivoxetine
| - | 0件: | - | - | - |
240 |
Egaptivon pegol
| - | 0件: | - | - | - |
241 |
Eliglustat
| 1件: Eliglustat Eliglustat | 2件: Cerdelga Cerdelga; Eliglustat; | 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
242 |
Enokizumab
| - | 0件: | - | - | - |
243 |
Ensituximab
| - | 0件: | - | - | - |
244 |
Erteberel
| - | 0件: | - | - | - |
245 |
Eteplirsen
| 1件: Eteplirsen Eteplirsen | 2件: ETEPLIRSEN ETEPLIRSEN; Exondys 51; | 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
246 |
Etrolizumab
| 1件: Etrolizumab Etrolizumab | 1件: ETROLIZUMAB ETROLIZUMAB; | 1件: ITGB7 ITGB7 💬 | 11件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | 2件: 96 96, 97 |
247 |
Emricasan
| - | 0件: | - | - | - |
248 |
Ensulizole
| - | 0件: | - | - | - |
249 |
Eplivanserin
| - | 0件: | - | - | - |
250 |
Efinaconazole
| - | 0件: | - | - | - |
251 |
Epelsiban
| - | 0件: | - | - | - |
252 |
Evacetrapib
| - | 0件: | - | - | - |
253 |
Enzalutamide
| - | 0件: | - | - | - |
254 |
Enobosarm
| - | 0件: | - | - | - |
255 |
Esflurbiprofen
| - | 0件: | - | - | - |
256 |
Ertugliflozin
| - | 0件: | - | - | - |
257 |
Elubrixin
| - | 0件: | - | - | - |
258 |
Elosulfase alfa
| 1件: Elosulfase alfa Elosulfase alfa | 3件: Elosulfase alfa Elosulfase alfa; Recombinant human N-acetylgalactosamine-6-sulfatase; RhGALNS; | 1件: GALNS GALNS 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
259 |
Emixustat
| 1件: Emixustat Emixustat | 1件: Emixustat Emixustat; | - | - | 1件: 301 301 |
260 |
Evodenoson
| - | 0件: | - | - | - |
261 |
Etirinotecan pegol
| - | 0件: | - | - | - |
262 |
Entolimod
| - | 0件: | - | - | - |
263 |
Eravacycline
| - | 0件: | - | - | - |
264 |
Eluxadoline
| - | 0件: | - | - | - |
265 |
Eldelumab
| - | 0件: | - | - | - |
266 |
Empagliflozin
| 1件: Empagliflozin Empagliflozin | 2件: Empagliflozin Empagliflozin; Jardiance; | 1件: SLC5A2 SLC5A2 💬 | - | 5件: 65 65, 72, 96, 97, 257 |
267 |
Ethacizine
| - | 0件: | - | - | - |
268 |
Eftrenonacog alfa
| - | 0件: | - | - | - |
269 |
Evolocumab
| 1件: Evolocumab Evolocumab | 2件: EVOLOCUMAB EVOLOCUMAB; Repatha; | 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 2件: 79 79, 222 |
270 |
Elbasvir
| - | 0件: | - | - | - |
271 |
Encenicline
| - | 0件: | - | - | - |
272 |
Etelcalcetide
| - | 0件: | - | - | - |
273 |
Evofosfamide
| - | 0件: | - | - | - |
274 |
Elobixibat
| 1件: Elobixibat Elobixibat | 1件: Elobixibat Elobixibat; | 1件: SLC10A2 SLC10A2 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 6 6 |
275 |
Emicizumab
| 1件: Emicizumab Emicizumab | 2件: Emicizumab Emicizumab; Hemlibra; | 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
276 |
Efmoroctocog alfa
| - | 0件: | - | - | - |
277 |
Esaxerenone
| - | 0件: | - | - | - |
278 |
Enasidenib
| - | 0件: | - | - | - |
279 |
Elamipretide
| 1件: Elamipretide Elamipretide | 1件: Elamipretide Elamipretide; | - | - | 2件: 21 21, 324 |
280 |
Entrectinib
| - | 0件: | - | - | - |
281 |
Erdafitinib
| - | 0件: | - | - | - |
282 |
Erenumab
| - | 0件: | - | - | - |
283 |
Etrasimod
| 1件: Etrasimod Etrasimod | 1件: Etrasimod Etrasimod; | 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 96 96, 97, 98 |
284 |
Etripamil
| - | 0件: | - | - | - |
285 |
Elapegademase
| 1件: Elapegademase Elapegademase | 2件: Elapegademase Elapegademase; Elapegademase-lvlr; | 1件: ADA ADA 💬 | 3件: Metabolic pathways Metabolic pathways, Primary immunodeficiency, Purine metabolism 💬 | 1件: 65 65 |
286 |
Evogliptin
| - | 0件: | - | - | - |
287 |
Epacadostat
| - | 0件: | - | - | - |
288 |
Encorafenib
| - | 0件: | - | - | - |
289 |
Evocalcet
| - | 0件: | - | - | - |
290 |
Emapalumab
| 1件: Emapalumab Emapalumab | 1件: EMAPALUMAB EMAPALUMAB; | 1件: IFNG IFNG 💬 | 32件: African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 49 49, 107 |
291 |
Eleclazine
| 1件: Eleclazine Eleclazine | 1件: Eleclazine Eleclazine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 58 58 |
292 |
Eflapegrastim
| - | 0件: | - | - | - |
293 |
Efizonerimod alfa
| - | 0件: | - | - | - |
294 |
Elafibranor
| 1件: Elafibranor Elafibranor | 1件: ELAFIBRANOR ELAFIBRANOR; | 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 |
295 |
Entospletinib
| - | 0件: | - | - | - |
296 |
Emactuzumab
| - | 0件: | - | - | - |
297 |
Eptinezumab
| - | 0件: | - | - | - |
298 |
Ensartinib
| - | 0件: | - | - | - |
299 |
Elezanumab
| 1件: Elezanumab Elezanumab | 1件: Elezanumab Elezanumab; | 1件: RGMA RGMA 💬 | 2件: Axon guidance Axon guidance, TGF-beta signaling pathway 💬 | 1件: 13 13 |
300 |
Elismetrep
| - | 0件: | - | - | - |
301 |
Etokimab
| - | 0件: | - | - | - |
302 |
Exebacase
| - | 0件: | - | - | - |
303 |
Eltanexor
| - | 0件: | - | - | - |
304 |
Elexacaftor
| 1件: Elexacaftor Elexacaftor | 3件: ELEXACAFTOR ELEXACAFTOR; Kaftrio; Trikafta; | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
305 |
Elenbecestat
| - | 0件: | - | - | - |
306 |
Estetrol
| 1件: Estetrol Estetrol | 1件: Estetrol Estetrol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 53 53 |
307 |
Estetrol
| 1件: Estetrol Estetrol | 1件: Estetrol Estetrol; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 53 53 |
308 |
Enarodustat
| - | 0件: | - | - | - |
309 |
Enfortumab vedotin
| - | 0件: | - | - | - |
310 |
Efinopegdutide
| - | 0件: | - | - | - |
311 |
Efavaleukin alfa
| 1件: Efavaleukin alfa Efavaleukin alfa | 1件: EFAVALEUKIN ALFA EFAVALEUKIN ALFA; | - | - | 2件: 49 49, 97 |
312 |
Edotreotide gallium Ga-68
| - | 0件: | - | - | - |
313 |
Exicorilant
| - | 0件: | - | - | - |
314 |
Elacestrant
| - | 0件: | - | - | - |
315 |
Ensifentrine
| - | 0件: | - | - | - |
316 |
Enoblituzumab
| - | 0件: | - | - | - |
317 |
Evinacumab
| 1件: Evinacumab Evinacumab | 1件: EVINACUMAB EVINACUMAB; | 1件: ANGPTL3 ANGPTL3 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
318 |
Efgartigimod alfa
| 1件: Efgartigimod alfa Efgartigimod alfa | 1件: EFGARTIGIMOD ALFA EFGARTIGIMOD ALFA; | 1件: FCGRT FCGRT 💬 | - | 4件: 11 11, 14, 35, 63 |
319 |
Enzastaurin
| - | 0件: | - | - | - |
320 |
Etesevimab
| - | 0件: | - | - | - |
321 |
Efpeglenatide
| - | 0件: | - | - | - |
322 |
Efmarodocokin alfa
| 1件: Efmarodocokin alfa Efmarodocokin alfa | 2件: Efmarodocokin alfa Efmarodocokin alfa; IL-22Fc; | 1件: IL22 IL22 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | 2件: 96 96, 97 |
323 |
Efineptakin alfa
| 1件: Efineptakin alfa Efineptakin alfa | 1件: NT-I7 NT-I7; | - | - | 1件: 25 25 |
324 |
Elasomeran
| 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 4件: COVID-19 Vaccine Moderna COVID-19 Vaccine Moderna; Elasomeran; Moderna COVID-19 Vaccine; Spikevax; | - | - | 5件: 13 13, 46, 51, 65, 299 |
325 |
Elivaldogene autotemcel
| 1件: Elivaldogene autotemcel Elivaldogene autotemcel | 1件: Elivaldogene autotemcel Elivaldogene autotemcel; | 1件: ABCD1 ABCD1 💬 | 2件: ABC transporters ABC transporters, Peroxisome 💬 | 1件: 20 20 |
326 |
Edasalonexent
| 1件: Edasalonexent Edasalonexent | 1件: EDASALONEXENT EDASALONEXENT; | 1件: RELA RELA 💬 | 76件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | 1件: 113 113 |
327 |
Esmethadone
| - | 0件: | - | - | - |